Literature DB >> 15674427

Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes.

Angela Clerk1, Peter H Sugden.   

Abstract

The extracellular signal-regulated kinases 1/2 (ERK1/2) are particularly implicated in the growth response of cardiac myocytes. In these cells, the ERK1/2 pathway is potently activated by Gq protein-coupled receptor agonists (such as endothelin-1 or alpha-adrenergic agonists), which activate protein kinase C isoforms. Here, we review the mechanisms associated with the activation of the ERK1/2 pathway by these agonists with particular emphasis on signal integration into the pathway. Signaling to the nucleus and the regulation of transcription factor activity associated with ERK1/2 activation in cardiac myocytes are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15674427     DOI: 10.1139/o04-110

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  9 in total

Review 1.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

2.  Functional modulation of sarcolemmal KATP channels by atrial natriuretic peptide-elicited intracellular signaling in adult rabbit ventricular cardiomyocytes.

Authors:  Dai-Min Zhang; Yu-Fung Lin
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

3.  Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?

Authors:  Xiang Wang; Ana-Maria Bosonea; Jeffrey Odenbach; Carlos Fernandez-Patron
Journal:  Curr Hypertens Rev       Date:  2012-08-01

4.  Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury.

Authors:  T Angelone; E Filice; T Pasqua; N Amodio; M Galluccio; G Montesanti; A M Quintieri; M C Cerra
Journal:  Cell Mol Life Sci       Date:  2012-09-07       Impact factor: 9.261

5.  N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms.

Authors:  Yanmei Zhang; Gaoyong Chen; Shuping Zhong; Fuchun Zheng; Fenfei Gao; Yicun Chen; Zhanqin Huang; Wenfeng Cai; Weiqiu Li; Xingping Liu; Yanshan Zheng; Han Xu; Ganggang Shi
Journal:  Oxid Med Cell Longev       Date:  2013-11-12       Impact factor: 6.543

6.  Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.

Authors:  Benjamin E Reinking; Elesa W Wedemeyer; Robert M Weiss; Jeffrey L Segar; Thomas D Scholz
Journal:  Cardiovasc Diabetol       Date:  2009-07-31       Impact factor: 9.951

7.  p90 ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and α(1)-adrenergic receptor agonists.

Authors:  Emre Amirak; Stephen J Fuller; Peter H Sugden; Angela Clerk
Journal:  Biochem J       Date:  2013-03-01       Impact factor: 3.857

8.  α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.

Authors:  Xiaohui Yu; Baoyin Jia; Faqiang Wang; Xiuxiu Lv; Xuemei Peng; Yiyang Wang; Hongmei Li; Yanping Wang; Daxiang Lu; Huadong Wang
Journal:  J Cell Mol Med       Date:  2013-12-05       Impact factor: 5.310

Review 9.  ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.

Authors:  Simona Gallo; Annapia Vitacolonna; Alessandro Bonzano; Paolo Comoglio; Tiziana Crepaldi
Journal:  Int J Mol Sci       Date:  2019-05-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.